GU Cancers 2023 | Unmet educational needs in GU cancers

Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, talks on the educational needs in genitourinary cancer (GU) cancers, including with antibody-drug conjugates (ADCs) for urothelial carcinoma, with biomarkers for PARP inhibitors in prostate cancer, and patient involvement for treatment decision making. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.